Literature DB >> 8577022

Gastrointestinal surface protection and mucosa reconditioning.

S Bengmark1, B Jeppsson.   

Abstract

BACKGROUND: There is increasing evidence that preservation of the ecology of the gastrointestinal tract and the surface protection system--surfactants, mucus, and fiber--is important for the outcome in postoperative trauma patients, patients after bone marrow and liver transplantation, and patients with HIV or AIDS. Approximately 50% of the nourishment of the small intestine and > 80% of the nourishment of the large intestine comes from the lumen. This is especially deleterious to the large intestine. Within less than a week of intestinal starvation--even in the presence of intense parenteral nutrition--a mucosal atrophy is observed, promoting translocation of potentially pathogenic microorganisms. Enteral nutrition is crucial to the outcome in many of these conditions. If however, such a nutrition is based on simple carbohydrates, peptides, amino acids, or fatty acids, most of the nutrition administered will be absorbed in the upper gastrointestinal tract. Complex fibers and proteins can be regarded as nutrients especially destined to the lower gastrointestinal tract. They are fermented by the probiotic flora, normally colonizing the colonic mucosa, and the necessary nutrients: short-chain fatty acids and amino acids such as arginine and glutamine are produced at the level of the colonic mucosa. Careless antibiotic treatment reduces or eliminates this flora, induces local mucosal starvation, and makes the patients vulnerable to opportunistic infections and microbial intestinal translocation. METHODS AND
RESULTS: In this review the role of the different ingredients of the surface protection system are discussed. A program to recondition the intestines, particularly the colonic mucosa by resupply of species-specific lactobacilli, surfactants, amino acids (especially glutamine), and oat fiber (beta-glucans) is suggested. Extensive experience in animal models and early experience in a patient population are summarized and discussed. Oat has been chosen as a substrate for fermentation because it contains 100 times more of membrane lipids (surfactants) than any other food, has a favorable amino acid pattern (rich in glutamine), and is rich in water-soluble, fermentable-fiber beta-glucans. More than 1000 isolates of human-specific lactobacilli have been studied. Some strains, especially those of plantarum type, have proven effective in colonizing the colonic mucosa, suppressing the potentially pathogenetic flora, and may have other probiotic effects as well.
CONCLUSION: A totally new enteral formula has been designed based on probiotic bacteria and fiber and aimed at colonizing the intestinal mucosa with a local probiotic effect and fermentation of fiber.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577022     DOI: 10.1177/0148607195019005410

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  14 in total

Review 1.  The origin of human milk bacteria: is there a bacterial entero-mammary pathway during late pregnancy and lactation?

Authors:  Juan M Rodríguez
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

Review 2.  Ecological control of the gastrointestinal tract. The role of probiotic flora.

Authors:  S Bengmark
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

3.  Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions.

Authors:  RadhaKrishna Rao; Geetha Samak
Journal:  J Epithel Biol Pharmacol       Date:  2012-01

4.  Probiotic bacteria stimulate gut epithelial cell proliferation in rat.

Authors:  H Ichikawa; T Kuroiwa; A Inagaki; R Shineha; T Nishihira; S Satomi; T Sakata
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

5.  The effect of reduced dietary glycine and serine and supplemental threonine on growth performance, protein deposition in carcass and viscera, and skin collagen abundance of nursery pigs fed low crude protein diets.

Authors:  Kayla E Silva; Lee-Anne Huber; Wilfredo D Mansilla; Anna K Shoveller; John K Htoo; John P Cant; Cornelis F M de Lange
Journal:  J Anim Sci       Date:  2020-05-01       Impact factor: 3.159

6.  Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.

Authors:  W Stremmel; U Merle; A Zahn; F Autschbach; U Hinz; R Ehehalt
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

7.  Effects of glutamine isomers on human (Caco-2) intestinal epithelial proliferation, strain-responsiveness, and differentiation.

Authors:  M Murnin; A Kumar; G D Li; M Brown; B E Sumpio; M D Basson
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

8.  L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.

Authors:  Miro Smriga; Kunio Torii
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

9.  Anti-inflammatory effects of phosphatidylcholine.

Authors:  Irina Treede; Annika Braun; Richard Sparla; Mark Kühnel; Thomas Giese; Jerrold R Turner; Elsa Anes; Hasan Kulaksiz; Joachim Füllekrug; Wolfgang Stremmel; Gareth Griffiths; Robert Ehehalt
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

10.  Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.

Authors:  Susanna Cunningham-Rundles; Siv Ahrné; Rosemary Johann-Liang; Rachel Abuav; Ann-Margaret Dunn-Navarra; Claudia Grassey; Stig Bengmark; Joseph S Cervia
Journal:  Nutrients       Date:  2011-12-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.